Angelini Ventures
Headquarter
Montreal, Quebec - Canada
Milestones
Founded: 2021
Invested: 2021
Founders / CEO
Clarissa Desjardins, CEO
Vertical
Biotech
Board Participation
Thomas Thestrup, Board Member
Developer of pharmacological stabilizer designed for the treatment of rare diseases. The company uses the interface of computational and experimental drug discovery, structural bioinformatics, computational chemistry, and machine learning to deploy an in silico platform that enables the design of a validated class of small molecules, enabling researchers to design novel small molecules for diseases of protein misfolding.